European Neuropsychopharmacology

1

The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)

Dell'Osso, Bernardo, Benatti, Beatrice, Buoli, Massimiliano, Altamura, A.Carlo, Marazziti, Donatella, Hollander, Eric, Fineberg, Naomi, Stein, Dan J., Pallanti, Stefano, Nicolini, Humberto, Ameringen,

Journal:

Year:

2013

Language:

english

File:

PDF, 470 KB

english, 2013

2

Playing it safe but losing anyway—Serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion

Macoveanu, Julian, Rowe, James B., Hornboll, Bettina, Elliott, Rebecca, Paulson, Olaf B., Knudsen, Gitte M., Siebner, Hartwig R.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 1.11 MB

english, 2013

3

Treating impaired cognition in schizophrenia: The case for combining cognitive-enhancing drugs with cognitive remediation

Michalopoulou, Panayiota G., Lewis, Shôn W., Wykes, Til, Jaeger, Judith, Kapur, Shitij

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 437 KB

english, 2013

4

Effect of modafinil on impulsivity and relapse in alcohol dependent patients: A randomized, placebo-controlled trial

Joos, Leen, Goudriaan, Anna E., Schmaal, Lianne, Fransen, Erik, van den Brink, Wim, Sabbe, Bernard G.C., Dom, Geert

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 729 KB

english, 2013

5

Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression

Nugent, Allison C., Bain, Earle E., Carlson, Paul J., Neumeister, Alexander, Bonne, Omer, Carson, Richard E., Eckelman, William, Herscovitch, Peter, Zarate, Carlos A., Charney, Dennis S., Drevets, Way

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 820 KB

english, 2013

6

Schizophrenia, antipsychotics and risk of hip fracture: A population-based analysis

Sørensen, Holger J., Jensen, Signe O.W., Nielsen, Jimmi

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 371 KB

english, 2013

7

Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies

Woods, Scott W., Walsh, Barbara C., Hawkins, Keith A., Miller, Tandy J., Saksa, John R., D'Souza, Deepak C., Pearlson, Godfrey D., Javitt, Daniel C., McGlashan, Thomas H., Krystal, John H.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 702 KB

english, 2013

9

The cost of mental disorders in France

Chevreul, Karine, Prigent, Amélie, Bourmaud, Aurélie, Leboyer, Marion, Durand-Zaleski, Isabelle

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 894 KB

english, 2013

10

Commentary on “Cognition in schizophrenia”

Green, Michael F.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 288 KB

english, 2013

11

AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment

Drago, Antonio, Giegling, Ina, Schäfer, Martin, Hartmann, Annette M., Friedl, Marion, Konte, Bettina, Möller, Hans-Jürgen, De Ronchi, Diana, Stassen, Hans H., Serretti, Alessandro, Rujescu, Dan

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 534 KB

english, 2013

12

The role of 5-HT in response inhibition and re-engagement

Drueke, Barbara, Schlaegel, Sonja M.A., Seifert, Anke, Moeller, Olaf, Gründer, Gerhard, Gauggel, Siegfried, Boecker, Maren

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 1.79 MB

english, 2013

13

Commentary on “Cognition in schizophrenia”

Harvey, Philip D.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 306 KB

english, 2013

14

Finally: A focus on cognition in schizophrenia

Kahn, René S.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 289 KB

english, 2013

15

BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: A prospective study

Buchmann, Arlette F., Hellweg, Rainer, Rietschel, Marcella, Treutlein, Jens, Witt, Stephanie H., Zimmermann, Ulrich S., Schmidt, Martin H., Esser, Günter, Banaschewski, Tobias, Laucht, Manfred, Deusch

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 426 KB

english, 2013

16

Comment on “Cognition in Schizophrenia: Summary Nice Consultation Meeting 2012”

Goldberg, Terry E., Gomar, Jesus J.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 305 KB

english, 2013

17

The DRD2 C957T polymorphism and the Attentional Blink—A genetic association study

Felten, Andrea, Montag, Christian, Kranczioch, Cornelia, Markett, Sebastian, Walter, Nora T., Reuter, Martin

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 522 KB

english, 2013

18

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo

Kaushal, Nidhi, Seminerio, Michael J., Robson, Matthew J., McCurdy, Christopher R., Matsumoto, Rae R.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 615 KB

english, 2013

19

Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder

Amital, D., Fostick, L., Silberman, A., Calati, R., Spindelegger, C., Serretti, A., Juven-Wetzler, A., Souery, D., Mendlewicz, J., Montgomery, S., Kasper, S., Zohar, J.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 355 KB

english, 2013

20

The potential role of dopamine D3 receptor neurotransmission in cognition

Nakajima, Shinichiro, Gerretsen, Philip, Takeuchi, Hiroyoshi, Caravaggio, Fernando, Chow, Tiffany, Le Foll, Bernard, Mulsant, Benoit, Pollock, Bruce, Graff-Guerrero, Ariel

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 630 KB

english, 2013

21

Cholinergic gating of hippocampal auditory evoked potentials in freely moving rats

Klinkenberg, Inge, Sambeth, Anke, Blokland, Arjan

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 679 KB

english, 2013

22

Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

Muguruza, Carolina, Moreno, José L., Umali, Adrienne, Callado, Luis F., Meana, J. Javier, González-Maeso, Javier

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 613 KB

english, 2013

23

Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: Studies with a mouse model of parkinsonian tremor

Salamone, John D., Collins-Praino, Lyndsey E., Pardo, Marta, Podurgiel, Samantha J., Baqi, Younis, Müller, Christa E., Schwarzschild, Michael A., Correa, Mercè

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 395 KB

english, 2013

24

Early prediction of clinical and functional outcome in schizophrenia

Agid, Ofer, Siu, Cynthia O., Pappadopulos, Elizabeth, Vanderburg, Douglas, Remington, Gary

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 518 KB

english, 2013

25

Editorial Board

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 32 KB

english, 2013

26

The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: A report of gender differences

Bloch, Miki, Meiboom, Hadas, Zaig, Inbar, Schreiber, Shaul, Abramov, Liora

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 580 KB

english, 2013

27

ECNP Calendar of Events

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 1.35 MB

english, 2013

28

The efficacy of agomelatine in previously-treated depressed patients

Kasper, Siegfried, Hajak, Göran

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 578 KB

english, 2013

29

Equipercentile linking of the BPRS and the PANSS

Leucht, S., Rothe, P., Davis, J.M., Engel, R.R.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 399 KB

english, 2013

30

Cognition in schizophrenia: Summary Nice Consultation Meeting 2012

Nutt, David, Gispen-de Wied, Christine C, Arango, Celso, Keefe, Richard SE, Penadés, Rafael, Murphy, Declan G, Robbins, Trevor W, Sahakian, Barbara J

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 408 KB

english, 2013

31

Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier

Menga, A., Infantino, V., Iacobazzi, F., Convertini, P., Palmieri, F., Iacobazzi, V.

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 931 KB

english, 2013

32

Commentary on “Regulatory issues in drug development programs targeting cognitive impairment in schizophrenia”

Laughren, Thomas

Journal:

European Neuropsychopharmacology

Year:

2013

Language:

english

File:

PDF, 291 KB

english, 2013

Volume 23; Issue 8

The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS)

Playing it safe but losing anyway—Serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion

Treating impaired cognition in schizophrenia: The case for combining cognitive-enhancing drugs with cognitive remediation

Effect of modafinil on impulsivity and relapse in alcohol dependent patients: A randomized, placebo-controlled trial

Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression

Schizophrenia, antipsychotics and risk of hip fracture: A population-based analysis

Contents

Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies

The cost of mental disorders in France

Commentary on “Cognition in schizophrenia”

AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment

The role of 5-HT in response inhibition and re-engagement

Commentary on “Cognition in schizophrenia”

Finally: A focus on cognition in schizophrenia

BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: A prospective study

Comment on “Cognition in Schizophrenia: Summary Nice Consultation Meeting 2012”

The DRD2 C957T polymorphism and the Attentional Blink—A genetic association study

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo

Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder

The potential role of dopamine D3 receptor neurotransmission in cognition

Cholinergic gating of hippocampal auditory evoked potentials in freely moving rats

Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects

Conditional neural knockout of the adenosine A2A receptor and pharmacological A2A antagonism reduce pilocarpine-induced tremulous jaw movements: Studies with a mouse model of parkinsonian tremor

Early prediction of clinical and functional outcome in schizophrenia

Editorial Board

The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: A report of gender differences

ECNP Calendar of Events

The efficacy of agomelatine in previously-treated depressed patients

Equipercentile linking of the BPRS and the PANSS

Cognition in schizophrenia: Summary Nice Consultation Meeting 2012

Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier

Commentary on “Regulatory issues in drug development programs targeting cognitive impairment in schizophrenia”